# Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome

> **NCT04802707** · PHASE2 · RECRUITING · sponsor: **Kenneth Myers, MD** · enrollment: 200 (estimated)

## Conditions studied

- Mitochondrial Diseases
- Mitochondrial Encephalomyopathy
- Mitochondrial Encephalopathy
- Mitochondrial DNA Depletion
- Mitochondrial Metabolism Disorders

## Interventions

- **COMBINATION_PRODUCT:** deoxycytidine and deoxythymidine

## Key facts

- **NCT ID:** NCT04802707
- **Lead sponsor:** Kenneth Myers, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-18
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04802707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04802707, "Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04802707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*